VENUS REMEDIES
Back to Balance Sheet
|
VENUS REMEDIES Last 5 Year Deferred Tax Assets / Liabilities History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | Mar2020 | Mar2019 | |
---|---|---|---|---|---|
Deferred Tax Assets / Liabilities | ₹11 Cr | ₹-0.68 Cr | ₹3.63 Cr | ₹17 Cr | ₹15 Cr |
What is the latest Deferred Tax Assets / Liabilities ratio of VENUS REMEDIES ?
Year | Deferred Tax Assets / Liabilities |
---|---|
Mar2023 | ₹11 Cr |
Mar2022 | ₹-0.68 Cr |
Mar2021 | ₹3.63 Cr |
Mar2020 | ₹17 Cr |
Mar2019 | ₹15 Cr |
How is Deferred Tax Assets / Liabilities of VENUS REMEDIES Trending?
Years | Deferred Tax Assets / Liabilities | % Change | |
---|---|---|---|
Mar2023 | ₹11 Cr | Positive | |
Mar2022 | ₹-0.68 Cr | Negative | |
Mar2021 | ₹3.63 Cr | -78.43 | |
Mar2020 | ₹17 Cr | 13.20 | |
Mar2019 | ₹15 Cr | - |
Compare Deferred Tax Assets / Liabilities of peers of VENUS REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VENUS REMEDIES | ₹438.2 Cr | -1.7% | 3.3% | 70% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹365,167.0 Cr | -2.3% | -6.5% | 55.3% | Stock Analytics | |
CIPLA | ₹113,645.0 Cr | 4.1% | -4.8% | 55.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹105,890.0 Cr | 7.8% | 17.4% | 20.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹104,987.0 Cr | 4% | 0.8% | 29.4% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹96,950.6 Cr | -1.2% | -5.2% | 83.9% | Stock Analytics |
VENUS REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VENUS REMEDIES | -1.7% |
3.3% |
70% |
SENSEX | 1.4% |
2.5% |
24.3% |
You may also like the below Video Courses